IBBQ:NSD-Invesco Nasdaq Biotechnology ETF (USD)

ETF | Others |

Last Closing

USD 19.64

Change

-0.39 (-1.95)%

Market Cap

USD 0.04B

Volume

6.80K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-16 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
IBIT iShares Bitcoin Trust

+0.30 (+0.63%)

USD 45.40B
QQQM Invesco NASDAQ 100 ETF

-0.04 (-0.02%)

USD 39.18B
JEPQ JPMorgan Nasdaq Equity Premium..

-0.02 (-0.04%)

USD 22.49B
ACWI iShares MSCI ACWI ETF

+0.47 (+0.42%)

USD 18.95B
CGABL The Carlyle Group Inc. 4.625% ..

+0.05 (+0.30%)

USD 16.14B
SNDK Sandisk Corp

-0.74 (-2.31%)

USD 5.99B
TBIL Rbb Fund Inc - Us Treasury 3 M..

+0.03 (+0.06%)

USD 5.43B
TSLL Direxion Shares ETF Trust - Di..

-0.02 (-0.26%)

USD 4.44B
NVDL GraniteShares 1.5x Long NVDA D..

-1.95 (-5.99%)

USD 3.04B
ETHA iShares Ethereum Trust ETF

-0.03 (-0.25%)

USD 2.37B

ETFs Containing IBBQ

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -8.74% 38% F 58% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -8.74% 38% F 58% F
Trailing 12 Months  
Capital Gain -4.24% 31% F 53% F
Dividend Return 0.68% 23% F 14% F
Total Return -3.56% 28% F 51% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 0.48% 47% F 43% F
Dividend Return 0.83% 41% F 39% F
Total Return 0.36% 28% F 11% F
Risk Return Profile  
Volatility (Standard Deviation) 11.81% 48% F 86% B+
Risk Adjusted Return 7.06% 35% F 42% F
Market Capitalization 0.04B 53% F 26% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.